Skip to Main Content

An official website of the United States government

Here you can browse the complete list of publications for studies listed on CDAS.

Publication Year
Title PubMed Authors Journal Year Studies
Non-steroidal anti-inflammatory drug use and the risk of benign prostatic hyperplasia-related outcomes and nocturia in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. 22429766 Sutcliffe S, Grubb Iii RL, Platz EA, Ragard LR, Riley TL, Kazin SS, Hayes RB, Hsing AW, Andriole GL, Urologic Diseases in America Project BJU Int. 2012 PLCO
Pancreatic cancer risk: associations with meat-derived carcinogen intake in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO) cohort. 22162237 Anderson KE, Mongin SJ, Sinha R, Stolzenberg-Solomon R, Gross MD, Ziegler RG, Mabie JE, Risch A, Kazin SS, Church TR Mol. Carcinog. 2012 PLCO
Serum IGF1, IGF2 and IGFBP3 and risk of advanced colorectal adenoma. 21932422 Gao Y, Katki H, Graubard B, Pollak M, Martin M, Tao Y, Schoen RE, Church T, Hayes RB, Greene MH, Berndt SI Int. J. Cancer 2012 PLCO
Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up. 22228146 Andriole GL, Crawford ED, Grubb RL, Buys SS, Chia D, Church TR, Fouad MN, Isaacs C, Kvale PA, Reding DJ, Weissfeld JL, Yokochi LA, O'Brien B, Ragard LR, Clapp JD, Rathmell JM, Riley TL, Hsing AW, Izmirlian G, Pinsky PF, Kramer BS, Miller AB, Gohagan… J. Natl. Cancer Inst. 2012 PLCO
Longitudinal evaluation of CA-125 velocity and prediction of ovarian cancer. 22198243 Xu JL, Commins J, Partridge E, Riley TL, Prorok PC, Johnson CC, Buys SS Gynecol. Oncol. 2012 PLCO
Tracking and tracing of participants in two large cancer screening trials. 22561392 Marcus PM, Childs J, Gahagan B, Gren LH Contemp Clin Trials 2012 NLST, PLCO
Meat consumption and the risk of incident distal colon and rectal adenoma. 22166801 Ferrucci LM, Sinha R, Huang WY, Berndt SI, Katki HA, Schoen RE, Hayes RB, Cross AJ Br. J. Cancer 2012 PLCO
Estrogen metabolism and risk of breast cancer in postmenopausal women. 22232133 Fuhrman BJ, Schairer C, Gail MH, Boyd-Morin J, Xu X, Sue LY, Buys SS, Isaacs C, Keefer LK, Veenstra TD, Berg CD, Hoover RN, Ziegler RG J. Natl. Cancer Inst. 2012 PLCO
Serum vitamin D and risk of bladder cancer in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening trial. 22623707 Mondul AM, Weinstein SJ, Horst RL, Purdue M, Albanes D Cancer Epidemiol. Biomarkers Prev. 2012 PLCO
The impact of PLCO control arm contamination on perceived PSA screening efficacy. 22488488 Gulati R, Tsodikov A, Wever EM, Mariotto AB, Heijnsdijk EA, Katcher J, de Koning HJ, Etzioni R Cancer Causes Control 2012 PLCO
Alcohol, genetics and risk of breast cancer in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. 22331481 McCarty CA, Reding DJ, Commins J, Williams C, Yeager M, Burmester JK, Schairer C, Ziegler RG Breast Cancer Res. Treat. 2012 PLCO
Proteomic biomarkers in combination with CA 125 for detection of epithelial ovarian cancer using prediagnostic serum samples from the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. 21717433 Moore LE, Pfeiffer RM, Zhang Z, Lu KH, Fung ET, Bast RC Cancer 2012 PLCO
Associations between genes in the one-carbon metabolism pathway and advanced colorectal adenoma risk in individuals with low folate intake. 22253295 Han SS, Sue LY, Berndt SI, Selhub J, Burdette LA, Rosenberg PS, Ziegler RG Cancer Epidemiol. Biomarkers Prev. 2012 PLCO
Factors associated with inadequate colorectal cancer screening with flexible sigmoidoscopy. 22112544 Laiyemo AO, Doubeni C, Pinsky PF, Doria-Rose VP, Sanderson AK, Bresalier R, Weissfeld J, Schoen RE, Marcus PM, Prorok PC, Berg CD Cancer Epidemiol 2012 PLCO
Aspirin but not ibuprofen use is associated with reduced risk of prostate cancer: a PLCO study. 22722313 Shebl FM, Sakoda LC, Black A, Koshiol J, Andriole GL, Grubb R, Church TR, Chia D, Zhou C, Chu LW, Huang WY, Peters U, Kirsh VA, Chatterjee N, Leitzmann MF, Hayes RB, Hsing AW Br. J. Cancer 2012 PLCO
Colorectal cancers not detected by screening flexible sigmoidoscopy in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. 22341106 Schoen RE, Pinsky PF, Weissfeld JL, Yokochi LA, Church T, Laiyemo AO, Bresalier R, Hickey T, Riley T, Prorok PC Gastrointest. Endosc. 2012 PLCO
Meta-analysis of new genome-wide association studies of colorectal cancer risk. 21761138 Peters U, Hutter CM, Hsu L, Schumacher FR, Conti DV, Carlson CS, Edlund CK, Haile RW, Gallinger S, Zanke BW, Lemire M, Rangrej J, Vijayaraghavan R, Chan AT, Hazra A, Hunter DJ, Ma J, Fuchs CS, Giovannucci EL, Kraft P, Liu Y, Chen L, Jiao S, Makar KW… Hum. Genet. 2012 PLCO
Flexible sigmoidoscopy in the randomized prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial: added yield from a second screening examination. 22298838 Weissfeld JL, Schoen RE, Pinsky PF, Bresalier RS, Doria-Rose VP, Laiyemo AO, Church T, Yokochi LA, Yurgalevitch S, Rathmell J, Andriole GL, Buys S, Crawford ED, Fouad M, Isaacs C, Lamerato L, Reding D, Prorok PC, Berg CD, PLCO Project Team J. Natl. Cancer Inst. 2012 PLCO
The association between inflammation-related genes and serum androgen levels in men: the prostate, lung, colorectal, and ovarian study. 21520164 Meyer TE, Chu LW, Li Q, Yu K, Rosenberg PS, Menashe I, Chokkalingam AP, Quraishi SM, Huang WY, Weiss JM, Kaaks R, Hayes RB, Chanock SJ, Hsing AW Prostate 2012 PLCO
Integrative genomic analysis reveals extended germline homozygosity with lung cancer risk in the PLCO cohort. 22384118 Orloff MS, Zhang L, Bebek G, Eng C PLoS ONE 2012 PLCO